Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Business Officer
-
Issuer Symbol
-
ETON on Nasdaq
David Krempa - trading volume in the past year for Eton Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
632,180 |
$10,747,060 |
$17.00 |
12 Dec 2025 |
Direct |
|
|
| Restricted Stock Units |
638,468 |
$206,527 |
$7.98 |
11 Dec 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (Right to Buy) |
38,621 |
|
|
03 Jan 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.